These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7779357)

  • 1. Combination vaccines: present practices and future possibilities.
    Ada G
    Biologicals; 1994 Dec; 22(4):329-31. PubMed ID: 7779357
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost benefit of combining antigens.
    Hadler SC
    Biologicals; 1994 Dec; 22(4):415-8. PubMed ID: 7779372
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined vaccines--the European contribution.
    Glück R
    Biologicals; 1994 Dec; 22(4):347-51. PubMed ID: 7779361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination for the new millennium.
    Baird MA; Buchan GS
    N Z Med J; 1998 Dec; 111(1079):461-2. PubMed ID: 9972198
    [No Abstract]   [Full Text] [Related]  

  • 5. Schistosomiasis vaccination. Historical development, present status and future prospects.
    Hsu HF; Hsu SY; Eveland LK
    Chin Med J (Engl); 1980 May; 93(5):297-312. PubMed ID: 6769643
    [No Abstract]   [Full Text] [Related]  

  • 6. Health economic research on vaccinations and immunisation practices--an introductory primer.
    Szucs TD
    Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vector vaccines in vaccinology.
    Hilleman MR
    Dev Biol Stand; 1994; 82():3-20. PubMed ID: 7958480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The science of adjuvants.
    Kwissa M; Kasturi SP; Pulendran B
    Expert Rev Vaccines; 2007 Oct; 6(5):673-84. PubMed ID: 17931149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
    Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
    Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a new combined vaccine in pediatric practices.
    Freed GL; Cowan AE; Clark SJ; Santoli J; Bradley J
    Pediatrics; 2006 Aug; 118(2):e251-7. PubMed ID: 16831895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present and future of vaccination for cutaneous leishmaniasis.
    Greenblatt CL
    Prog Clin Biol Res; 1980; 47():259-85. PubMed ID: 7010374
    [No Abstract]   [Full Text] [Related]  

  • 12. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cellular vaccines and genetic adjuvants against bacterial kidney disease in chinook salmon (Oncorhynchus tshawytscha).
    Rhodes LD; Rathbone CK; Corbett SC; Harrell LW; Strom MS
    Fish Shellfish Immunol; 2004 Apr; 16(4):461-74. PubMed ID: 15123289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
    Jacobs RJ; Rosenthal P; Meyerhoff AS
    Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, acceptance, and use of immunologic correlates of protection in monitoring the effectiveness of combination vaccines.
    Edwards KM
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S274-7. PubMed ID: 11709759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial barriers to implementing combination vaccines: perspectives from pediatricians and policy makers.
    Gidengil CA; Rusinak D; Allred NJ; Luff D; Lee GM; Lieu TA
    Clin Pediatr (Phila); 2009 Jun; 48(5):539-47. PubMed ID: 19318705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and efficacy assessment of combination vaccines, with emphasis on acellular pertussis.
    Hauser P; De Grave D; Zepp F; Poolman J; Slaoui M
    Dev Biol Stand; 1998; 95():251-5. PubMed ID: 9855439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the development of new vaccines against tuberculosis.
    Orme IM
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):95-100. PubMed ID: 9441089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.